Service de médecine nucléaire et imagerie moléculaire

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


950 publications

... | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | ...
 
Intérêt de la tomographie par émission de positons couplée à la scanographie (TEP/TDM) dans les cancers urologiques [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
Boujelbene N., Prior J.O., Boubaker A., Azria D., Schaffer M., Gez E., Jichlinski P., Meuwly J.Y., Mirimanoff R.O., Ozsahin M. et al., 2011. Cancer Radiothérapie, 15 (4) pp. 307-315.
 
Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia
Le Renard Pol-E. , Lortz R., Senatore C., Rapin J.P., Buchegger F., Petri-Fink A., Hofmann H., Doelker E., Jordan O., 2011. Journal of Magnetism and Magnetic Materials, 323 (8) pp. 1054-1063. Peer-reviewed.
 
Pericardial fat volume correlates with coronary vasomotion
Dunet V., Dabiri A., Allenbach G., Achigar A. G., Waeber B., Feihl F., Heinzer R., Prior J. O., 2011. pp. A1 dans 10th International Conference of Non Invasive Cardiovascular Imaging, European Heart Journal Supplements. Peer-reviewed.
 
Peritoneal carcinomatosis due to ovarian cancer: comparison between MDCT, MRI and positron emission tomography-computed tomography with F18-fluorodeoxyglucose
Schmidt S., Meuli R., Prior J., 2011. dans ESGAR 2011, European Society of Gastrointestinal and Abdominal Radiology.
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
Park S.I., Shenoi J., Frayo S.M., Hamlin D.K., Lin Y., Wilbur D.S., Stayton P.S., Orgun N., Hylarides M., Buchegger F. et al., 2011. Clinical Cancer Research, 17 (23) pp. 7373-782.
 
Prostate cancer: F-18-fluorocholine PET-CT utility. [Cancer de la prostate : utilité de la TEP-TDM à la 18F-fluorocholine.]
Boubaker A., Houzard C., Zouhair A., Got P., Orcurto M.V., Giammarile F., 2011. Médecine Nucléaire, 35 (8) pp. 446-454. Peer-reviewed.
 
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the international radioimmunotherapy network.
Hohloch K., Delaloye A.B., Windemuth-Kieselbach C., Gómez-Codina J., Linkesch W., Jurczak W., Cacchione R., Suh C., Zinzani P.L., Trümper L., 2011. Journal of Nuclear Medicine, 52 (9) pp. 1354-1360.
Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma.
Buchegger F., Press O.W., 2011. EJNMMI Research, 1 (1) p. 7.
 
Six of 12 Relapsed or Refractory Indolent Lymphoma Patients Treated 10 Years Ago with 131I-Tositumomab Remain in Complete Remission.
Buchegger F., Antonescu C., Helg C., Kosinski M., Prior J.O., Delaloye A.B., Press O.W., Ketterer N., 2011. Journal of Nuclear Medicine, 52 (6) pp. 896-900.
 
Successful bilateral lung transplantation after previous pneumonectomy
Gonzalez M., Ris H.B., Krueger T., Ferrari E., Chollet-Rivier M., Marcucci C., Prior J.O., Jayet P.Y., Mazza-Stalder J., Aubert J.D., 2011. pp. 21-22 dans 98th Annual Congress of the Swiss Society of Surgery, British Journal of Surgery. Peer-reviewed.
 
Successful bilateral lung transplantation after previous pneumonectomy.
Ris H.B., Krueger T., Gonzalez M., Ferrari E., Chollet-Rivier M., Marcucci C., Prior J., Jayet P.Y., Aubert J.D., 2011. Annals of Thoracic Surgery, 91 (4) pp. 1302-1304. Peer-reviewed.
 
Synthesis of F-18-labeled cyclic-[RGDfK] peptides for PET imaging of angiogenesis
Monaco A., Michelin O., Prior J., Scapozza L., Seimbille Y., 2011. pp. S499 dans 19th International Symposium on Radiopharmaceutical Sciences, Journal of Labelled Compounds and Radiopharmaceuticals. Peer-reviewed.
 
The prognostic value of semi-quantitative i-123 mibg scintigraphy at diagnosis in high risk neuroblastoma: validation of the siopen score method
Ladenstein R., Poetschger U., Boubaker A., Bar-Sever Z., Drake B., Staudenherz A., Castellani M.R., Lambert B., Grange K., Brock P. et al., 2011. pp. 732-733 dans 43rd Congress of the International Society of Paediatric Oncology, Pediatric Blood and Cancer. Peer-reviewed.
 
Évaluation de la perfusion myocardique par TEP-TDM. [Myocardial perfusion imaging using PET/CT.]
Dunet V., Prior J.O., 2011. Médecine Nucléaire, 35 (5) pp. 336-343. Peer-reviewed.
 
Radioimmunotherapy in non-Hodgkin lymphoma: opinions of U.S. medical oncologists and hematologists.
Schaefer N.G., Ma J., Huang P., Buchanan J., Wahl R.L., 2010/06. Journal of nuclear medicine, 51 (6) pp. 987-994. Peer-reviewed.
 
The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schaefer Niklaus, 2010/05. dans The Laryngoscope.
 
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Bombardieri Emilio, Ambrosini Valentina, Aktolun Cumali, Baum Richard P., Bishof-Delaloye Angelica, Del Vecchio Silvana, Maffioli Lorenzo, Mortelmans Luc, Oyen Wim, Pepe Giovanna et al., 2010. European Journal of Nuclear Medicine and Molecular Imaging, 37 (7) pp. 1441-1448.
 
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Giammarile F., Aktolun C., Baum R.P., Bischof Delaloye A., Maffioli L., Moncayo R., Mortelmans L., Pepe G., Reske S.N. et al., 2010. European Journal of Nuclear Medicine and Molecular Imaging, 37 (12) pp. 2436-2446.
 
Absence of residual Hodgkin's disease demonstrated by PET/CT in a deceased organ donor.
Prior J.O., Duchosal M.A., Schmidt S., Turini P., Pilon N., Chioléro R., Pascual M., 2010/01. Transplant international, 23 (1) pp. 101-104. Peer-reviewed.
 
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
Cirstoiu-Hapca A., Buchegger F., Lange N., Bossy L., Gurny R., Delie F., 2010. Journal of Controlled Release, 144 (3) pp. 324-331.
 
Charge dependent substrate activity of C3' and N3 functionalized, organometallic technetium and rhenium-labeled thymidine derivatives toward human thymidine kinase 1.
Struthers Harriet, Viertl David, Kosinski Marek, Spingler Bernhard, Buchegger Franz, Schibli Roger, 2010. Bioconjugate Chemistry, 21 (4) pp. 622-634.
 
Diagnostic Performances of 18F-FDG Positron Emission Tomography in Large Vessels Vasculitis: Meta-analysis
Besson F., Parienti J., Prior J., Bienvenu B., Costo S., Bouvard G., Agostini D., 2010. pp. S467 dans 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European Journal Of Nuclear Medicine And Molecular Imaging. Peer-reviewed.
 
Diffusion-weighted MRI in metastatic gastrointestinal tumors (GIST): A pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT
Koehli M., Dunet V., Montemurro M., Leyvraz S., Meuli R., Prior J.O., Schmidt S., 2010. p. 12 dans Swiss Radiological Congress 2010, Schweizerische Gesellschaft für Radiologie, Schweizerische Gesellschaft für Nuklearmedizin, Schweizerische Vereinigung der Fachleute für medizinisch technische Radiologie, Swiss Medical Forum = Forum Médical Suisse.
 
Effects of added dead space on sleep disordered breathing at high altitude
Lovis A., De Riedmatten M., Greiner D., Delaloye A., Sartori C., Scherrer U., Heinzer R., 2010. p. 3 dans Joint annual meeting of the Swiss Society of Pneumology, Swiss Society of Pediatric Pneumology, Swiss Society for Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Endothelial dependant coronary vasoreactivity measured by 82Rb cardiac PET in obstructive sleep apnea patients before and after CPAP treatment
Heinzer R., Dunet V., Rey V., Beysard N., Delaloye A., Jayet P.-Y., Lovis A., Bonetti A., Prior J., 2010. p. 3 dans Joint annual meeting of the Swiss Society of Pneumology, Swiss Society of Pediatric Pneumology, Swiss Society for Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Endothelial dysfunction in systemic lupus erythematosus: evaluation with 13N-ammonia PET.
Alexánderson E., Ochoa J.M., Calleja R., Juárez-Rojas J.G., Prior J.O., Jácome R., Romero E., Meave A., Posadas-Romero C., 2010. Journal of Nuclear Medicine, 51 (12) pp. 1927-1931.
 
Glioblastoma Expressing Mgmt Contribution Of Patrin-2 In Radiotherapy with Temozolomide
Perillo-Adamer F., Buchegger F., Ruegg C., Mirimanoff O., 2010. p. 719 dans 14th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.
 
Incremental Prognostic Value of Myocardial Blood Flow Quantification with Rb-82 Cardiac PET in Patients With Known or Suspected CAD
Farhad H., Dunet V., Allenbach G., Soubeyran V., Coendoz N., El Hakmaoui F., Camus F., Kosinski M., Prior J. O., 2010. pp. S301 dans 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European Journal Of Nuclear Medicine And Molecular Imaging. Peer-reviewed.
 
IRM de diffusion et GIST métastatique : évaluation de la réponse thérapeutique comparée à la 18-FDG-TEP-TDM
Koehli M., Dunet V., Montemurro M., Leyvraz S., Meuli R., Prior J.O., Schmidt S., 2010. p. 1324 dans JFR 2010, 58e Journées Françaises de Radiologie, Journal de Radiologie. Peer-reviewed.
 
Micropapillary pattern in lung adenocarcinoma: aspect on 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Prior J.O., Stupp R., Christodoulou M., Letovanec I., 2010. Interactive Cardiovascular and Thoracic Surgery, 10 (1) pp. 144-145.
 
Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers.
Zouhair A., Ozsahin M., Schaffer M., Albrecht S., Camus F., Jichlinski P., Mirimanoff R.O., Delaloye A.B., Meuwly J.Y., Prior J.O., 2010. Current Medicinal Chemistry, 17 (23) pp. 2492-502.
 
Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death.
Golay J., Bologna L., André P.A., Buchegger F., Mach J.P., Boumsell L., Introna M., 2010. Blood, 116 (17) pp. 3372-3373.
 
Sarcoïdose extrapulmonaire: entité méconnue [Extrapulmonary sarcoidosis: an unrecognized disease entity?].
Lyko C., Bart P.A., Pruvot E., Prior J., Waeber G., 2010. Revue Médicale Suisse, 6 (269) pp. 2056-2060.
Syllabus for postgraduate specialisation in Nuclear Medicine : 2006/07 update.
Cuocolo A., Milcinski M., Bischof Delaloye A., 2010. European Journal of Nuclear Medicine and Molecular Imaging, 37 (2) pp. 430-433.
 
Textiloma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a wolf in a sheep's clothing?
Petermann D., Christodoulou M., Petermann David, Christodoulou Michel, Letovanec Igor, Gengler Carole, Doenz Francesco, Orcurto Victoria, Ris Hans-Beat, Prior John O., 2010. Journal of Thoracic Oncology, 5 (2) pp. 280-281. Peer-reviewed.
 
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia.
Le Renard P.E., Jordan O., Faes A., Petri-Fink A., Hofmann H., Rüfenacht D., Bosman F., Buchegger F., Doelker E., 2010. Biomaterials, 31 (4) pp. 691-705. Peer-reviewed.
 
The management of brain metastases
Mirimanoff R.O., 2010. pp. S15 dans 2nd European Lung Cancer Conference, Journal of Thoracic Oncology. Peer-reviewed.
 
Three-dimensional ordered-subset expectation maximization iterative protocol for evaluation of left ventricular volumes and function by quantitative gated SPECT: a dynamic phantom study.
Ceriani L., Ruberto T., Delaloye A.B., Prior J.O., Giovanella L., 2010. Journal of Nuclear Medicine Technology, 38 (1) pp. 18-23.
 
Toxicity And Dose Constraints With Adjuvant Imrt For Endometrial Cancers
Hallenbarter M., Loessl K., Bouchaab H., Aebersold D.M., Pica A., 2010. p. 735 dans 14th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Strahlentherapie und Onkologie. Peer-reviewed.
 
Transient Ischemic Dilation (TID) ratio measurement during Rb-82 cardiac PET: Comparison between three different software packages.
El Hakmaoui F., Malterre J., Recordon M., Pappon M., Buchs M., Kosinski M., Prior J., Dunet V., 2010. pp. S485 dans 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European Journal of Nuclear Medicine and Molecular Imaging. Peer-reviewed.
 
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia.
Cicone F Stalder M Geiger D Cairoli A Delaloye AB Prior JO, 2010. Nuklearmedizin, 49 (2) pp. N10-12.
 
Y-90 Ibritumomab Tiuxetan (Zevalin (R)) Consolidation of First Remission In Advanced Stage Follicular Non Hodgkin's Lymphoma Updated Results After a Median Follow up of 662 Months From the International, Randomized, Phase III First Line Indolent Trial (FIT) In 414 Patients
Hagenbeek A., Radford J., Van Hoof A., Vitolo U., Rohatiner A. Z.S., Salles G., Soubeyran P., Tilly H., Delaloye A.B., van Putten W. L.J. et al., 2010. pp. 261-262 dans 52nd Annual Meeting of the American-Society-of-Hematology, Blood. Peer-reviewed.
 
Bellini duct carcinoma: visualization on F-18 FDG PET/CT.
Marx K., Bauer J., Guillou L., Delaloye A.B., Prior J., 2009. Clinical Nuclear Medicine, 34 (8) pp. 541-542.
 
Chronic facial twitches: when tracers reveal their status.
Siclari F., Prior J.O., Orcurto V., Maeder P., Rossetti A.O., 2009. European Journal of Neurology, 16 (8) pp. e149-e150.
 
Comparison of magnetic resonance enterography and video capsule endoscopy in evaluating small bowel disease.
Crook D.W., Knuesel P.R., Froehlich J.M., Eigenmann F., Unterweger M., Beer H.J., Kubik-Huch R.A., 2009. European Journal of Gastroenterology and Hepatology, 21 (1) pp. 54-65.
 
Consolidation with Radioimmunotherapy May Prolong Survival in First Remission of Mantle Cell Lymphoma Patients Uneligible for Stem Cell Transplantation, An Analysis of the International RIT-Network
Jurczak Wojciech, Skotnicki Aleksander B., Deptala Andrzej, Windemuth-Kieselbach Christine, Lorsbach Michael, Delaloye Angelika Bischof, Cheolwon Suh, Zinzani Pier Luigi, Cacchione Roberto, Linkesch Werner et al., 2009. p. 1442 dans 51st Annual Meeting of the American Society of Hematology, Blood. Peer-reviewed.
 
Contribution of PaTrin-2 in Radiotherapy with Temozolomide for the Treatment of Glioblastoma Expressing MGMT
Perillo-Adamer F., Buchegger F., Rueegg C., Mirimanoff R., 2009. pp. 557-558 dans 51st Annual Meeting of the American-Society-for-Radiation-Oncology, International Journal of Radiation Oncology Biology Physics. Peer-reviewed.
 
Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
Orcurto M.V., Bischof Delaloye A., Letovanec I., Martins Favre M., Prior J.O., 2009. Journal of Thoracic Oncology, 4 (1) pp. 127-130.
 
Dosimetry of 90Y-ibritumomab tiuxetan as consolidation of first remission in advanced-stage follicular lymphoma: results from the international phase 3 first-line indolent trial.
Delaloye Angelika Bischof, Antonescu Cristian, Louton Thomas, Kuhlmann Jens, Hagenbeek Anton, 2009. Journal of Nuclear Medicine, 50 (11) pp. 1837-1843. Peer-reviewed.
 
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior J.O., Montemurro M., Orcurto M.V., Michielin O., Luthi F., Benhattar J., Guillou L., Elsig V., Stupp R., Delaloye A.B. et al., 2009. Journal of Clinical Oncology, 27 (3) pp. 439-445. Peer-reviewed.
 
Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors.
Schindler T.H., Campisi R., Dorsey D., Prior J.O., Olschewski M., Sayre J., Schelbert H.R., 2009. European Heart Journal, 30 (8) pp. 978-986.
 
Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine.
Perillo-Adamer F., Kosinski M., Dupertuis Y.M., Viertl D., Bischof Delaloye A., Buchegger F., 2009. Nuklearmedizin. Nuclear Medicine, 48 (6) pp. 233-242. Peer-reviewed.
 
Intrapancreatic accessory spleen : case study
Al Qahtani S., Ocurto M.V., Schnyder P., Bischoff-Delaloye A., Schmidt S., 2009. Diagnostic Imaging Europe, 25 (7) pp. 10. novembre 2009.
 
La surveillance active dans la prise en charge du cancer de la prostate précoce. [Active surveillance for early-stage prostate cancer]
Jichlinski P., Berthold D. R., Zouhair A., Griesser A. C., Meuwly J. Y., Prior J. O., Lhermitte B., Doerfler A., Treuthardt C., Praz V. et al., 2009. Revue médicale suisse, 5 (228) pp. 2442-4, 2446-7.
 
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model.
Renard P.E., Buchegger F., Petri-Fink A., Bosman F., Rüfenacht D., Hofmann H., Doelker E., Jordan O., 2009. International journal of hyperthermia, 25 (3) pp. 229-239.
 
Myocardial perfusion scintigraphy in diabetes : current status and limitations
Prior J.O., 2009. pp. 305-324 dans Movahed A., Gnanasegaran G., Buscombe J.R., Hall M. (eds.) Integrating cardiology for nuclear medicine physicians : a guide to nuclear medicine physicians chap. 27, Springer.
 
Myocardial perfusion study with 82-Rubidium in the clinical setting: Feasibility and advantages over the conventional myocardial SPECT
Allenbach G., Dunet V., Kosinski M., Camus F., Malterre J., Verdun F., Bischof Delaloye A., Prior J., 2009. dans SGR-SSR 2009, 96th Annual Swiss Congress of Radiology.
 
Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.
Cirstoiu-Hapca A., Buchegger F., Bossy L., Kosinski M., Gurny R., Delie F., 2009. European Journal of Pharmaceutical Sciences, 38 (3) pp. 230-237.
 
New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction.
Bischof Delaloye A., Conti P.S., Gisselbrecht C., Gregory S.A., 2009. Oncologist, 14 (Suppl. 2) pp. 1-3.
 
New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary.
Bischof Delaloye A., Conti P.S., Gisselbrecht C., Gregory S.A., 2009. Oncologist, 14 (Suppl. 2) pp. 52-54.
 
Positron Emission Tomography: Principles and Clinical Applications
Schaefer Niklaus, 2009. dans Husband and Reznek's Imaging in Oncology, Taylor and Francis Ltd.
 
Postmortem dynamic CT-angiography : P30
Grabherr S., Doenz F., Gygax E., Bollmann M., Schmidt S., Meuli R., Mangin P., Meuli R., 2009. pp. 27S dans SGR-SSR 2009, 96th Annual Swiss Congress of Radiology, Swiss Medical Forum = Forum Médical Suisse.
 
Radionuclide Imaging of Musculoskeletal Disorders in Children
Boubaker Ariane, 2009. pp. 211-218 dans Hodler J., Schulthess G.K., Zollikofer C.L. (eds.) Musculoskeletal Diseases 2009-2012 : Diagnostic Imaging : 41st International Diagnostic Course in Davos (IDKD).
 
Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
Morschhauser F., Dreyling M., Rohatiner A., Hagemeister F., Bischof Delaloye A., 2009. Oncologist, 14 (Suppl. 2) pp. 17-29.
 
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Weber D.C., Casanova N., Zilli T., Buchegger F., Rouzaud M., Nouet P., Vees H., Ratib O., Dipasquale G., Miralbell R., 2009. Radiotherapy and oncology, 93 (3) pp. 586-592. Peer-reviewed.
 
Response evaluation in third- and fourth-line treatment of GIST: the role of PET
Montemurro M., Prior J., Leyvraz S., 2009. p. 398 dans 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, EJC Supplements. Peer-reviewed.
 
Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.
Schindler T.H., Facta A.D., Prior J.O., Cadenas J., Zhang X.L., Li Y., Sayre J., Goldin J., Schelbert H.R., 2009. European Journal of Nuclear Medicine and Molecular Imaging, 36 (2) pp. 219-229. Peer-reviewed.
 
The role of I-123-hippuran(OIH) renography (RG) in the presurgical, work-up of laparoscopic live kidney donors : SS421
Nicod Lalonde M., Venetz J.P., Matter M., Qanadli S., Bischof Delaloye A., 2009. dans SGR-SSR 2009, 96th Annual Swiss Congress of Radiology.
 
Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.
Steiner C.h., Vees H., Zaidi H., Wissmeyer M., Berrebi O., Kossovsky M.P., Khan H.G., Miralbell R., Ratib O., Buchegger F., 2009. Nuklearmedizin. Nuclear medicine, 48 (1) pp. 1-9; quiz N2-3. Peer-reviewed.
 
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant.
Lienard D., Avril M.F., Le Gal F.A., Baumgaertner P., Vermeulen W., Blom A., Geldhof C., Rimoldi D., Pagliusi S., Romero P. et al., 2009. Journal of immunotherapy, 32 (8) pp. 875-883. Peer-reviewed.
 
Value of positron emission tomography in full-thickness chest wall resections for malignancies.
Petermann D., Allenbach G., Schmidt S., Letovanec I., Christodoulou M., Bischof Delaloye A., Ris H.B., Prior J.O., 2009. Interactive Cardiovascular and Thoracic Surgery, 9 (3) pp. 406-410.
 
[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.
Weber D.C., Zilli T., Buchegger F., Casanova N., Haller G., Rouzaud M., Nouet P., Dipasquale G., Ratib O., Zaidi H. et al., 2008. Radiation Oncology, 3 (44) pp. [11 p.]. Peer-reviewed.
 
Abnormal coronary vasomotion in presence of metabolic syndrome components: potential implications for Switzerland
Prior J.O., Allenbach G., Masson J.C., Schelbert H.R., Darioli R., 2008. pp. 8 S dans XVI. Schweizer Atherosklerose-Meeting = XVIe Réunion Suisse d'Athérosclérose, Kardiovaskuläre Medizin.
 
Apports de la médecine nucléaire en cardiologie préventive: l'exemple du syndrome métabolique [Value of nuclear medicine in preventive cardiology: the metabolic syndrome example]
Prior J.O., Allenbach G., Masson J.C., Darioli R., 2008. Revue Médicale Suisse, 4 (148) pp. 644-649.
 
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E., Pascual M., Nicod M., Delaloye A.B., Duchosal M.A., 2008. Transplantation, 85 (5) pp. 707-712. Peer-reviewed.
 
Effects of long-term estrogen replacement therapy in postmenopausal women with coronary risk factors
Campisi R., Schindler T. H., Prior J. O., Zhang X. L., Dorsey D., Schelbert H. R., 2008. pp. E426-E427 dans World Congress of Cardiology, Circulation. Peer-reviewed.
 
Evaluation of therapeutic effects of monoclonal antibodies, directed against cluster of differentiation expressed by B-chronic lymphocitic B-cell leukaemia, in vitro and in vivo : P245
Andre P.A., Bischof Delaloye A., Kosinski M., Viertl D., Buchegger F., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
Haemoptysis and complete atrioventricular block.
Pascale P., Prior J.O., Carron P.N., Pruvot E., Muller O., 2008. European Heart Journal, 29 (11) p. 1396.
 
Imagerie cardiaque non invasive: apport spécifique en clinique des nouvelles modalités (I). Evaluation morphologique [Cardiac imaging: specific clinical role of newly developed non invasive techniques. Part 1: Morphological evaluation].
Monney P., Prior J.O., Rizzo E., Locca D., Bischof D.A., Qanadli S., Jeanrenaud X., 2008. Revue Médicale Suisse, 4 (159) pp. 1304-1310.
 
Imagerie cardiaque non invasive: apport spécifique en clinique des nouvelles modalités (II). Evaluation fonctionnelle [Cardiac imaging: specific clinical role of newly developed non invasive techniques. Part II: functional evaluation].
Monney P., Prior J.O., Rizzo E., Locca D., Bischof D.A., Qanadli S.D., Jeanrenaud X., 2008. Revue Médicale Suisse, 4 (159) pp. 1311-1317.
 
MIBG scintigraphy for the diagnosis and follow-up of children with neuroblastoma.
Boubaker A., Bischof Delaloye A., 2008. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 52 (4) pp. 388-402.
 
Prognostic Value of FDG-PET/CT in Therapy Response Evaluation of Malignant Pleural Mesothelioma
Schaefer Niklaus, 2008. European Journal of Nuclear Medicine and Molecular Imaging, 35.
 
Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution
Roulin D., Matter M., Bady P., Lienard D., Gugerli O., Boubaker A., Bron L., Lejeune F. J., 2008. European Journal of Surgical Oncology, 34 (6) pp. 673-679. Peer-reviewed.
 
Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma
Buchegger F., Press O. W., Delaloye Bischof A., Ketterer N., 2008. Oncologist, 13 (6) pp. 657-667. Peer-reviewed.
 
Trends in disability related to cardiovascular diseases in Switzerland between 1987 and 2006
Darioli R., Prior J., Perdrix J., 2008. pp. 3 S dans XVI. Schweizer Atherosklerose-Meeting = XVIe Réunion Suisse d'Athérosclérose, Kardiovaskuläre Medizin.
 
Well-differentiated papillary mesothelioma of the tunica vaginalis testis: imaging on Tc-99m heat-denatured red blood cell scintigraphy.
Chollet Y., Hauser P., Da Silva T., Meuwly J.Y., Praz V., Jichlinski P., Guillou L., Delaloye A.B., Wisard M., Prior J., 2008. Clinical Nuclear Medicine, 33 (4) pp. 282-284. Peer-reviewed.
 
Clinical quality management in telenuclear medicine
Als C., Bischof Delaloye A., 2007/11. European Journal of Nuclear Medicine and Molecular Imaging, 34 (11) pp. 1727-8.
 
Effect of an immunonutrient mix on human colorectal adenocarcinoma cell growth and viability
Dupertuis Y. M., Benais-Pont G., Buchegger F., Pichard C., 2007/09. Nutrition, 23 (9) pp. 672-80.
 
Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET
Schindler T. H., Zhang X. L., Prior J. O., Cadenas J., Dahlbom M., Sayre J., Schelbert H. R., 2007/08. European Journal of Nuclear Medicine and Molecular Imaging, 34 (8) pp. 1178-88. Peer-reviewed.
 
White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging.
Bischof Delaloye A., Carrió I., Cuocolo A., Knapp W., Gourtsoyiannis N., McCall I., Reiser M., Silberman B., 2007/08. European Journal of Nuclear Medicine and Molecular Imaging, 34 (8) pp. 1147-1151. Peer-reviewed.
 
White paper of the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) on multimodality imaging.
Gourtsoyiannis N., McCall I., Reiser M., Silberman B., Bischof Delaloye A., Carrió I., Cuocolo A., Knapp W., 2007/08. European Radiology, 17 (8) pp. 1926-1930. Peer-reviewed.
 
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy
Vees H., Buchegger F., Albrecht S., Khan H., Husarik D., Zaidi H., Soloviev D., Hany T. F., Miralbell R., 2007/06. BJU International, 99 (6) pp. 1415-20.
 
A pitfall of propidium iodide staining in fluorescence-activated cell sorting cell cycle analysis?
Buchegger F., Dupertuis Y. M., Perillo-Adamer F., 2007/06. Cancer Research, 67 (11) pp. 5576-7; author reply 5577.
 
Initial report of PET/CT-guided radiofrequency ablation of liver metastases.
Prior J.O., Kosinski M., Delaloye A.B., Denys A., 2007/06. Journal of Vascular and Interventional Radiology, 18 (6) pp. 801-803. Peer-reviewed.
 
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)
Tennvall J., Fischer M., Bischof Delaloye A., Bombardieri E., Bodei L., Giammarile F., Lassmann M., Oyen W., Brans B., 2007/04. European Journal of Nuclear Medicine and Molecular Imaging, 34 (4) pp. 616-22.
 
Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles
Cirstoiu-Hapca A., Bossy-Nobs L., Buchegger F., Gurny R., Delie F., 2007/03. International Journal of Pharmaceutics, 331 (2) pp. 190-6.
 
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes
Schindler T. H., Facta A. D., Prior J. O., Cadenas J., Hsueh W. A., Quinones M. J., Schelbert H. R., 2007/03. Heart, 93 (3) pp. 345-9. Peer-reviewed.
 
Persistent FDG uptake around an inguinal mesh prosthesis 25 years after implantation.
Koljevic-Markovic A., Orcurto M.V., Doenz F., Delaloye A.B., Prior J.O., 2007/03. Clinical Nuclear Medicine, 32 (3) pp. 242-243. Peer-reviewed.
 
(11)C-acetate PET in the early evaluation of prostate cancer recurrence
Albrecht S., Buchegger F., Soloviev D., Zaidi H., Vees H., Khan H. G., Keller A., Bischof Delaloye A., Ratib O., Miralbell R., 2007/02. European Journal of Nuclear Medicine and Molecular Imaging, 34 (2) pp. 185-96.
 
Comparaison des performances de deux systemes TEP/TDM corps entier selon la norme NEMA NU 2-2001
Modolo L., Bolard G., Prior J. O., Seimbille ., Kosinski M., Hejira N., Delaloye A.B., Bochud F., Verdun F. R., 2007. Médecine Nucleaire, 31 (8) pp. 372-379. Peer-reviewed.
 
Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans
Prior J. O., Schindler T. H., Facta A. D., Hernandez-Pampaloni M., Campisi R., Dahlbom M., Schelbert H. R., 2007/01. European Journal of Nuclear Medicine and Molecular Imaging, 34 (1) pp. 20-7. Peer-reviewed.
Endoscopic and surgical treatment of vesico-ureteral reflux in children. Comparative long-term follow-up.
Oberson C., Boubaker A., Ramseyer P., Meyrat B.J., Frey P., 2007. Swiss Medical Weekly, 137 (33-34) pp. 471-475. Peer-reviewed.
 
Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer.
Delaloye J.F., Pampallona S., Chardonnens E., Fiche M., Lehr H.A., De Grandi P., Delaloye A.B., 2007. Gynecologic Oncology, 106 (1) pp. 89-93. Peer-reviewed.
 
Investigation et prise en charge du nodule pulmonaire solitaire dans un environnement multidisciplinaire
Prior J.O., Schmidt S., Ris H.-B., Delaloye A.B., 2007. Medecine Nucleaire, 31 (8) pp. 380-387.
 
Les arterites des grands vaisseaux: maladie de Horton et maladie de Takayasu. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis]
Petitpierre S., Bart P. A., Leimgruber A., Prior J., Spertini F., 2007. Revue Médicale Suisse, 3 (108) pp. 1056-60, 1062-3.
 
Performance comparison of two commercial BGO-based PET/CT scanners using NEMA NU 2-2001.
Bolard G., Prior J.O., Modolo L., Delaloye A.B., Kosinski M., Wastiel C., Malterre J., Bulling S., Bochud F., Verdun F.R., 2007. Medical Physics, 34 (7) pp. 2708-2717. Peer-reviewed.
 
Radio-immunothérapie du lymphome folliculaire: un pas vers la guérison [Radioimmunotherapy of follicular lymphoma: a step towards cure?]
Ketterer N., Bischof Delaloye A., Helg C., Luthi F., Buchegger F., 2007. Bulletin du cancer, 94 (9) pp. 799-806.
 
Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma.
Willi J.P., Matter M., Buchegger F., Antonescu C., Guggisberg D., Cerottini J.P., Krischer J., Braun R., Marie Kurt A., Roche B. et al., 2007. Nuklearmedizin. Nuclear medicine, 46 (6) pp. 244-251. Peer-reviewed.
 
Successful migration of three tracers without identification of sentinel nodes during intraoperative lymphatic mapping for non-small cell lung cancer.
Meyer A., Cheng C., Antonescu C., Pezzetta E., Bischof-Delaloye A., Ris H.B., 2007. Interactive Cardiovascular and Thoracic Surgery, 6 (2) pp. 214-218.
Suppressing bladder artifacts in bone SPECT of the pelvis.
Allenbach G., Prior J.O., Theumann N., El-Hasnawy N., Malterre J., Delaloye A.B., Kamel E.M., 2007. Annals of Nuclear Medicine, 21 (6) pp. 339-344. Peer-reviewed.
Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update.
Cuocolo A., Milcinski M., Bischof Delaloye A., 2007. European Journal of Nuclear Medicine and Molecular Imaging, 34 (3) pp. 433-436.
 
The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients.
Matter M., Nicod Lalonde M., Allaoua M., Boubaker A., Liénard D., Gugerli O., Cerottini J.P., Bouzourene H., Bischof Delaloye A., Lejeune F., 2007. Journal of Nuclear Medicine, 48 (10) pp. 1607-1613. Peer-reviewed.
 
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients
Walton S. M., Gerlinger M., de la Rosa O., Nuber N., Knights A., Gati A., Laumer M., Strauss L., Exner C., Schafer N. et al., 2006/12. Journal of Immunology, 177 (11) pp. 8212-8. Peer-reviewed.
 
The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology
Marcassa C., Bischof Delaloye A., Cuocolo A., Hesse B., Kaufmann P., Knuuti J., Le Guludec D., Sochor H., Underwood R., Vassiliadis I. et al., 2006/12. European Journal of Nuclear Medicine and Molecular Imaging, 33 (12) pp. 1508-12.
Auger radiation targeted into DNA: a therapy perspective
Buchegger F., Perillo-Adamer F., Dupertuis Y. M., Bischof Delaloye A., 2006/11. European Journal of Nuclear Medicine and Molecular Imaging, 33 (11) pp. 1352-63.
 
PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction
Schindler T. H., Facta A. D., Prior J. O., Campisi R., Inubushi M., Kreissl M. C., Zhang X. L., Sayre J., Dahlbom M., Schelbert H. R., 2006/10. European Journal of Nuclear Medicine and Molecular Imaging, 33 (10) pp. 1140-9. Peer-reviewed.
 
omega-3 Polyunsaturated fatty acids and ionizing radiation: Combined cytotoxicity on human colorectal adenocarcinoma cells
Benais-Pont G., Dupertuis Y. M., Kossovsky M. P., Nouet P., Allal A. S., Buchegger F., Pichard C., 2006/09. Nutrition, 22 (9) pp. 931-9.
 
Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET
Kreissl M. C., Wu H. M., Stout D. B., Ladno W., Schindler T. H., Zhang X., Prior J. O., Prins M. L., Chatziioannou A. F., Huang S. C. et al., 2006/06. Journal of Nuclear Medicine, 47 (6) pp. 974-80. Peer-reviewed.
 
Paediatric CT: up to what level can patient dose be decreased?
Gutierrez D., Verdun F., Prior J., Lepori D., Gudinchet F., 2006/06. pp. 18S dans SSR 93ème Congrès annuel SGR-SSR, Lausanne, CHUV, Forum médical suisse.
Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine.
Perillo-Adamer F., Delaloye A.B., Genton C.S., Schaffland A.O., Dupertuis Y.M., Buchegger F., 2006/05. European Journal of Nuclear Medicine and Molecular Imaging, 33 (5) pp. 613-620. Peer-reviewed.
 
Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function
Schindler T. H., Cardenas J., Prior J. O., Facta A. D., Kreissl M. C., Zhang X. L., Sayre J., Dahlbom M., Licinio J., Schelbert H. R., 2006/03. Journal of the American College of Cardiology, 47 (6) pp. 1188-95. Peer-reviewed.
 
Biodegradable nanoparticles for direct or two-step tumor immunotargeting
Nobs L., Buchegger F., Gurny R., Allemann E., 2006/02. Bioconjugate Chemistry, 17 (1) pp. 139-45.
 
The European board of nuclear medicine fellowship examination
Pons F., Bischof Delaloye A., 2006/02. European Journal of Nuclear Medicine and Molecular Imaging, 33 (2) pp. 109-10.
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
Baumgaertner P., Rufer N., Devevre E., Derre L., Rimoldi D., Geldhof C., Voelter V., Liénard D., Romero P., Speiser D.E., 2006. Cancer Research, 66 (4) pp. 1912-1916. Peer-reviewed.
 
Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.
Kamel E.M., Jichlinski P., Prior J.O., Meuwly J.Y., Delaloye J.F., Vaucher L., Malterre J., Castaldo S., Leisinger H.J., Delaloye A.B., 2006. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 (11) pp. 1803-7. Peer-reviewed.
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.
Buchegger F., Antonescu C., Delaloye A.B., Helg C., Kovacsovics T., Kosinski M., Mach J.P., Ketterer N., 2006. British journal of cancer, 94 (12) pp. 1770-1776. Peer-reviewed.
 
Radionuclide investigations of the urinary tract in the era of multimodality imaging.
Boubaker A., Prior J.O., Meuwly J.Y., Bischof-Delaloye A., 2006. Journal of Nuclear Medicine, 47 (11) pp. 1819-1836.
 
Scintigraphie myocardique dans l'évaluation du risque cardiovasculaire périopératoire
Prior J.O., 2006. p. 253 dans Albrecht E., Haberer J.P., Buchser E. (eds.) Manuel Pratique d'Anesthésie, Masson.
 
SPECT myocardial perfusion imaging: long-term prognostic value in diabetic patients with and without coronary artery disease.
Koehli M., Monbaron D., Prior J.O., Calcagni M.L., Fivaz-Arbane M., Stauffer J.C., Gaillard R.C., Bischof Delaloye A., Ruiz J., 2006. Nuklearmedizin. Nuclear medicine, 45 (2) pp. 74-81. Peer-reviewed.
 
Apport du PET en oncologie. [PET contribution in oncology]
Zimmermann M., Luthi F., Zouhair A., Ketterer N., Prior J. O., Kamel M. E., Bischof-Delaloye A., 2005/05. Revue Médicale Suisse, 1 (20) pp. 1335-8, 1341-2.
 
Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus
Prior J. O., Quinones M. J., Hernandez-Pampaloni M., Facta A. D., Schindler T. H., Sayre J. W., Hsueh W. A., Schelbert H. R., 2005/05. Circulation, 111 (18) pp. 2291-8. Peer-reviewed.
 
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis
Busso N., Wagtmann N., Herling C., Chobaz-Peclat V., Bischof-Delaloye A., So A., Grouzmann E., 2005/02. American Journal of Pathology, 166 (2) pp. 433-442.
 
Ankle sprain and medial osteochondral lesion of the talus : report of a case with unclear symptomatology and the value of open curettage and drilling in the presence of a cartilage defect and subchondral osteosclerosis.
Crevoisier X., Theumann N., Boubaker A., Chevalley F., 2005. Osteosynthesis and Trauma Care, 13 (2) pp. 118-124.
 
Des radioisotopes qui traquent la maladie - rôle irremplaçable de la médecine nucléaire
Bischof Delaloye A., Allaoua M., Boubaker A., Buchegger F., Castaldo S., Kamel E. M., Prior J., 2005. Les cahiers de l 'électricité - revue suisse de l 'énergie, 60 pp. 24-29.
 
Dilatation pyélocalicielle chez le nouveau-né: attitude pratique pour le pédiatre [Antenatally detected hydronephrosis: practical approach for the pediatrician]
Cachat F., Ramseyer P., Meyrat B.J., Frey P., Boubaker A., Lepori D., Parvex P., Bugmann P., Girardin E., 2005. Revue médicale suisse, 1 (7) pp. 505-512.
 
Evaluation of a multicomponent worksite health promotion program for cardiovascular risk factors-correcting for the regression towards the mean effect.
Prior J.O., van Melle G., Crisinel A., Burnand B., Cornuz J., Darioli R., 2005. Preventive Medicine, 40 (3) pp. 259-67. Peer-reviewed.
 
Intercomparison of activity measurements for beta-emitters in Swiss nuclear medicine laboratories.
Wastiel C., Valley J.F., Delaloye A.B., Leresche M., Linder R., Sassowsky M., Bochud F.O., 2005. Journal of Nuclear Medicine Technology, 33 (4) pp. 238-242.
Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies.
Kamel E.M., McKee T.A., Calcagni M.L., Schmidt S., Markl S., Castaldo S., Delaloye A.B., 2005. European Journal of Nuclear Medicine and Molecular Imaging, 32 (6) pp. 641-646. Peer-reviewed.
 
Portrait de membre: Prof. Angelika Bischof Delaloye. La médecine, une affaire de famille.
Forbat A, 2005. Courrier du médecin vaudois, 11 p. 15.
Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy.
Prior J.O., Monbaron D., Koehli M., Calcagni M.L., Ruiz J., Bischof Delaloye A., 2005. European journal of nuclear medicine and molecular imaging, 32 (1) pp. 60-9. Peer-reviewed.
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics.
Antonescu C., Bischof Delaloye A., Kosinski M., Monnin P., Schaffland A.O., Ketterer N., Grannavel C., Kovacsovics T., Verdun F.R., Buchegger F., 2005. European journal of nuclear medicine and molecular imaging, 32 (8) pp. 943-51. Peer-reviewed.
 
Effect of peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, on dedifferentiated thyroid cancers
Philips J. C., Petite C., Willi J. P., Buchegger F., Meier C. A., 2004/12. Nuclear Medicine Communications, 25 (12) pp. 1183-6.
 
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting
Nobs L., Buchegger F., Gurny R., Allemann E., 2004/11. European Journal of Pharmaceutics and Biopharmaceutics, 58 (3) pp. 483-90.
 
131I-rituximab: relationship between immunoreactivity and specific activity
Schaffland A. O., Buchegger F., Kosinski M., Antonescu C., Paschoud C., Grannavel C., Pellikka R., Bischof Delaloye A., 2004/10. Journal of Nuclear Medicine, 45 (10) pp. 1784-90.
 
A new method of thermoablation with hot water vapour for localized tumours
Hiltbrand E., Belenger J., Binzoni T., Buchegger F., Costa M., Mehier H., 2004/10. Anticancer Research, 24 (5A) pp. 2757-63.
 
Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors
Schindler T. H., Nitzsche E. U., Olschewski M., Magosaki N., Mix M., Prior J. O., Facta A. D., Solzbach U., Just H., Schelbert H. R., 2004/08. Circulation, 110 (9) pp. 1069-75. Peer-reviewed.
 
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs L., Buchegger F., Gurny R., Allemann E., 2004/08. Journal of Pharmaceutical Sciences, 93 (8) pp. 1980-92.
 
Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine
Coucke P. A., Cottin E., Azria D., Martineau P., Adamer F., Decosterd L. A., Buchegger F., Do H. P., 2004/07. European Journal of Cancer, 40 (10) pp. 1572-1580.
 
Myocardial viability in patients with ischemic cardiomyopathy-evaluation by 3-D integration of myocardial scintigraphic data--and coronary angiographic data
Schindler T. H., Nitzsche E. U., Magosaki N., Mix M., Facta A. D., Prior J. O., Solzbach U., Schelbert H. R., Just H., 2004/06. Molecular Imaging and Biology, 6 (3) pp. 160-71. Peer-reviewed.
 
Ovarian cancer management. Practice guidelines for nuclear physicians
Classe J. M., Fontanelli R., Bischof-Delaloye A., Chatal J. F., 2004/06. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 48 (2) pp. 143-9.
 
The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
Schaffland A.O., Delaloye A.B., Kosinski M., Dupertuis Y.M., Buchegger F., 2004/05. Nuclear medicine communications, 25 (5) pp. 461-468. Peer-reviewed.
 
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab
Beyer G. J., Miederer M., Vranjes-Duric S., Comor J. J., Kunzi G., Hartley O., Senekowitsch-Schmidtke R., Soloviev D., Buchegger F., 2004/04. European Journal of Nuclear Medicine and Molecular Imaging, 31 (4) pp. 547-54.
 
Analyse de la prescription, de l'efficacité et de la tolérance des inhibiteurs de l'acétylcholinestérase dans la maladie d'Alzheimer
Nicod Lalonde M., Lleshi E., Coutaz M., Morisod J., 2004. Rev Med Suisse, 0.23971.
 
Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors.
Schindler TH, Nitzsche EU, Olschewski M, Magosaki N, Mix M, Prior JO, Facta AD, Solzbach U, Just H, Schelbert HR, 2004. Circulation, 110 pp. 1069-1075.
 
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.
Liénard D., Rimoldi D., Marchand M., Dietrich P.Y., van Baren N., Geldhof C., Batard P., Guillaume P., Ayyoub M., Pittet M.J. et al., 2004. Cancer Immunity, 4 p. 4.
 
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
Buchegger F., Adamer F., Schaffland A.O., Kosinski M., Grannavel C., Dupertuis Y.M., de Tribolet N., Mach J.P., Delaloye A.B., 2004. International Journal of Cancer, 110 (1) pp. 145-149. Peer-reviewed.
 
La mesure du poids et du tour de taille : une précieuse source simple et peu coûteuse d'informations pour la prévention cardiovasculaire
Darioli R., Perdrix J., Masson J. C., Giusti V., Prior J. O., 2004. Médecine et Hygiène, 62 (2470) pp. 399-405.
 
Nuclear Cardiology - Clinical Applications of Positron Emission Tomography.
Schelbert H.R, Prior J.O, 2004. dans Ell P.J, Gambhir S.S (eds.) Nuclear Medicine in Clinical Diagnosis and Treatment,3rd Edition, Churchill Livingstone.
 
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography.
Schindler T.H., Nitzsche E.U., Olschewski M., Brink I., Mix M., Prior J., Facta A., Inubushi M., Just H., Schelbert H.R., 2004. Journal of Nuclear Medicine, 45 (3) pp. 419-28. Peer-reviewed.
 
Peter Ell: portrait of an editor.
Bischof Delaloye A., Højgaard L., Knuuti J., 2004. European journal of nuclear medicine and molecular imaging, 31 (1) pp. 3-4. Peer-reviewed.
 
Place du FDG PET-Scan dans la prise en charge chirurgicale du carcinome pulmonaire non à petites cellules
Pezzetta E., Haller C., Deglise S., Rey J., El-Lamaa Z., Ris H. B., Bischof Delaloye A., 2004. Médecine et Hygiène, 62 (2465) pp. 81-92.
 
Positron Emission Tomography for the Noninvasive Study and Quantitation of Myocardial Blood Flow and Metabolism in Cardiovascular Disease.
Schelbert H.R., Prior J.O., 2004. dans Fuster V, Alexander R.W., O'Rourke R.A., King S.B. (eds.) The Heart, Hurst's New York, McGraw-Hill.
 
Exclusion of pulmonary embolism using C-reactive protein and D-dimer. A prospective comparison.
Aujesky D., Hayoz D., Yersin B., Perrier A., Barghouth G., Schnyder P., Bischof-Delaloye A., Cornuz J., 2003/12. Thrombosis and haemostasis, 90 (6) pp. 1198-1203. Peer-reviewed.
 
Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
Rimoldi D., Lemoine R., Kurt A.M., Salvi S., Berset M., Matter M., Roche B., Cerottini J.P., Guggisberg D., Krischer J. et al., 2003/10. Melanoma research, 13 (5) pp. 511-520. Peer-reviewed.
 
Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients
Buchegger F., Bonvin F., Kosinski M., Schaffland A. O., Prior J., Reubi J. C., Blauenstein P., Tourwe D., Garcia Garayoa E., Bischof Delaloye A., 2003/10. Journal of Nuclear Medicine, 44 (10) pp. 1649-54.
 
Laparoscopic right nephrectomy for live kidney donation: functional results
Bettschart V., Boubaker A., Martinet O., Golshayan D., Wauters J. P., Mosimann F., 2003/06. Transplant International, 16 (6) pp. 419-24.
 
Un reseau pour la recherche du ganglion sentinelle du cancer du sein. [Network for sentinel lymph node research in breast cancer]
Delaloye J. F., Monod J. F., Friedli A., Burgener F., Stalder J. B., Fiche M., De Grandi P., Bischof Delaloye A., 2003/05. Revue Médicale de la Suisse Romande, 123 (5) pp. 299-302.
 
Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy
Boubaker A., Bischof Delaloye A., 2003/03. Quarterly Journal of Nuclear Medicine, 47 (1) pp. 31-40.
 
Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy
Pugnale N., Waridel F., Bouzourene H., Boubaker A., Pugnale M., Gaillard R. C., Gomez F., 2003/03. European Journal of Endocrinology, 148 (3) pp. 357-64.
 
A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells.
Dupertuis Y.M., Buchegger F., Pichard C., 2003/02. Cancer Biotherapy & [and] Radiopharmaceuticals, 18 (1) pp. 7-16. Peer-reviewed.
 
Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine
Buchegger F., Vieira J. M., Blaeuenstein P., Dupertuis Y. M., Schaffland A. O., Grannavel C., de Tribolet N., Slosman D. O., Bischof Delaloye A., 2003/02. European Journal of Nuclear Medicine and Molecular Imaging, 30 (2) pp. 239-46.
 
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP140-147. Peer-reviewed.
 
131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP132-139. Peer-reviewed.
 
67Ga scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP125-131. Peer-reviewed.
 
Bone scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Morteímans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP99-106. Peer-reviewed.
 
Breast scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP107-114. Peer-reviewed.
 
Editorial perspective--advances in B-cell non-Hodgkin's lymphoma
Hagenbeek A., Bischof Delaloye A., 2003. Leukemia and Lymphoma, 44 Suppl 4 pp. S1-4.
 
FDG-PET: procedure guidelines for tumour imaging.
Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., 2003. European Journal of Nuclear Medicine and Molecular Imaging, 30 (12) pp. BP115-124. Peer-reviewed.
 
La radiothérapie systémique des métastases osseuses
Boubaker A., Bischof Delaloye A., 2003. Médecine et Hygiène, 61 (2461) pp. 2395-2401.
 
Revue du traitement chirurgical du mélanome malin : [Cancer Surgical treatment of malignant melanoma]
Matter M., Lejeune F., Antonescu C., Bischof Delaloye A., Gugerli O., Lobrinus A., Cerottini J. P., Guggisberg D., Liénard D., 2003. Médecine et Hygiène, 61 (2438) pp. 1088-1097.
 
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods
Nobs L., Buchegger F., Gurny R., Allemann E., 2003/01. International Journal of Pharmaceutics, 250 (2) pp. 327-37.
 
The role of nuclear medicine in the treatment of non-Hodgkin's lymphoma (NHL)
Bischof Delaloye A., 2003. Leukemia and Lymphoma, 44 Suppl 4 pp. S29-36.
 
The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
Prior J.O., Barghouth G., Delaloye J.F., Leyvraz S., Bischof Delaloye A., 2003/01. Nuclear medicine communications, 24 (1) pp. 29-36. Peer-reviewed.
 
Un réseau pour la recherche du ganglion sentinelle du cancer du sein
Delaloye J. F., Monod J. F., Friedli A., Burgener F., Stalder J. B., Fiche M., de Grandi P., Bischof Delaloye A., 2003. Revue Médicale de la Suisse Romande, 123 pp. 299-302.
 
Unilateral ureteropelvic junction obstruction in children: long-term followup after unilateral pyeloplasty.
Boubaker A., Prior J.O., Meyrat B., Bischof Delaloye A., McAleer I.M., Frey P., 2003. The Journal of urology, 170 (2 Pt 1) pp. 575-9; discussion 579. Peer-reviewed.
 
Unilateral urinary flow impairment at the pelviureteral junction: outcome of renal function with respect to therapeutic strategy.
Boubaker A., Meyrat B., Frey P., Bischof Delaloye A., 2003. Urology, 61 (6) pp. 1224-8; discussion 1228-9.
 
Unilateral urinary flow impairment at the pelviureteric junction : Outcome of renal function with respect to therapeutic strategy .
Boubaker A, Meyrat B, Frey P, Bischof Delaloye A, 2003. Urology, 61(6) pp. 1224-1229.
 
VQ Scanning in the Era of CT Angiography and PET
Bischof Delaloye A., Barghouth G., 2003. dans IKDK 2003, 35th International Diagnostic Course.
 
Lymphoscintigraphy in a patient with polyserositis of unknown origin
Prior J. O., Boubaker A., Spertini F., Bischof Delaloye A., 2002/12. Clinical Nuclear Medicine, 27 (12) pp. 905-6.
 
Dose calculation pitfall
Blauenstein P., Bruhlmeier M., Buchegger F., 2002/10. Journal of Nuclear Medicine, 43 (10) pp. 27N; author reply 28N.
 
Nutrition et croissance tumorale. [Nutrition and tumoral growth]
Dupertuis Y. M., Raguso C. A., Buchegger F., Pichard C., 2002/07. Revue Médicale de la Suisse Romande, 122 (7) pp. 319-23.
 
Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas
Dupertuis Y. M., Xiao W. H., De Tribolet N., Pichard C., Slosman D. O., Bischof Delaloye A., Buchegger F., 2002/04. European Journal of Nuclear Medicine and Molecular Imaging, 29 (4) pp. 499-505.
 
Apport des recommandations suisses pour la prise en charge du facteur cholestérol dans la population active
Darioli R., Miozzari A., Prior J., Perdrix J., 2002. Cardiovasc, 5 pp. 32-39.
 
Can chest X-ray be included in a decisional algorithm for patients suspected of pulmonary embolism diagnosis?
Barghouth G., Prior J.O., Cornuz J., Bischof Delaloye A., Schnyder P., 2002. p. 390 dans ECR 2002, European Congress of Radiology, European Radiology.
 
Does a saline bolus after contrast injection increases liver, portal and aortic enhancement in CT? A prospective evaluation
Chalaron M., Denys A., Chevallier P., Prior J.O., Qanadli S, Schnyder P., 2002. pp. 224-224 dans RSNA 2002, 88th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Radiology. Peer-reviewed.
 
Ganglion sentinelle et cancer du sein: le point en 2002
Delaloye J.F., Bischof Delaloye A., Genton C., de Grandi P., 2002. Références en gynécologie obstétrique, 9 pp. 21-28.
 
Laparoscopic procurement of kidney grafts from living donors does not impair initial renal function.
Bettschart V., Vallet C., Golshayan D., Halabi G., Schneider R., Bischof-Delaloye A., Boubaker A., Wauters J.P., Mosimann F., 2002. Transplantation proceedings, 34 (3) pp. 787-90. Peer-reviewed.
 
Paranasal sinuses in children: size evaluation of maxillary, sphenoid, and frontal sinuses by magnetic resonance imaging and proposal of volume index percentile curves.
Barghouth G., Prior J.O., Lepori D., Duvoisin B., Schnyder P., Gudinchet F., 2002. European radiology, 12 (6) pp. 1451-1458. Peer-reviewed.
 
Progress in the diagnosis and treatment of disease by nuclear medicine and molecular imaging: highlights of the European Association of Nuclear Medicine Congress, Naples 2001
Bischof Delaloye A., 2002/01. European Journal of Nuclear Medicine and Molecular Imaging, 29 (1) pp. 139-59.
 
Répercussions de la sédentarité sur le profil des facteurs de risque cardiovasculaire et le risque d'accident coronarien chez les employés d'entreprises du canton de Vaud [Repercussion of sedentarity on cardiovascular risk profile among employeees of companies in Western Switzerland]
Darioli R., Mooser V., Perdrix J., Cornuz J., Crisinel A., Gilliéron J.M., Prior J., 2002. Médecine et Hygiène, 60 (2383) pp. 567-572.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University